[ad_1]
Urzula Ponderrayen, President of the European Union (EU). / Photo = AP
Bloomberg reported on the 11th that it has approved all 27 export cases so far in relation to the vaccine export approval system for the new coronavirus infection (Corona 19) recently introduced by the European Union.
According to Bloomberg, the European Commission, a member of the EU administration, said last week that it approved four shipments of vaccines to Canada, Japan and the United Kingdom, followed by 23 exports of additional vaccines.
Recent approvals included vaccine exports to Australia, China, Mexico, New Zealand, Oman and Saudi Arabia.
Earlier, since 30 last month, the EU introduced a system that requires pharmaceutical companies to obtain approval from member states when they export the Corona 19 vaccine produced in the EU outside the region. This is the result of growing concern about the lack of supply of the COVID-19 vaccine and the slow rate of vaccination.
Consequently, pharmaceutical companies must notify member countries of new export plans in advance and provide information on export targets and quantities. If the established criteria are not met, member states can block exports.
“We have no intention of restricting companies that respect contracts with the EU. Europe is always ready to help,” he said.
Regarding the new export approval system for vaccines against coronavirus infection (Corona 19) recently introduced by the European Union (EU), it has approved 27 exports so far. The photos are not related to the article. / Photo = Getty Image Bank
The EU Commission has so far signed supply contracts with pharmaceutical companies in each country on behalf of 27 member states with a population of 450 million to secure 2.3 billion doses of a COVID-19 vaccine that has already been approved. or is in development.
Among them, the EU approved the use of three vaccines developed by Pfizer-German Bioentech, US Modena and the multinational pharmaceutical company AstraZeneca-Oxford University in the UK.
Meanwhile, the World Health Organization (WHO) has raised concerns about the EU scheme, saying: “It is not helpful in the current situation not to allow the free flow of ingredients needed to make vaccines or other pharmaceuticals.”
Bobae Lee, Guest Reporter for Hankyung.com [email protected]
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution
